Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: Evidence for electrophilic and non-electrophilic mechanisms

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 397, Issue 2, 1998, Pages 313-335

  Henry, B ^a   Grant, S G ^a   Klopman, G ^b   Rosenkranz, H S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Chromosome missegregation; Gene inactivation; Molecular carcinogenesis; MultiCASE; Mutation; Recombination; Segregation; Structure activity relationships; Tumor suppressor gene

Indexed keywords

MUTAGENIC AGENT; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CHEMICAL MUTAGENESIS; CHROMOSOME ANALYSIS; DATA BASE; EXPERT SYSTEM; GENE LOCUS; GENE SEGREGATION; GENETIC RECOMBINATION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; DATABASES, FACTUAL; LYMPHOMA; MICE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; SALMONELLA TYPHIMURIUM; STRUCTURE-ACTIVITY RELATIONSHIP; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

ANIMALIA; SALMONELLA;

EID: 0032472925     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00231-5     Document Type: Article

References (63)

1. Clive D., Flamm W.G., Macheska M.R., Bernheim N.J. A mutational assay using the thymidine kinase locus in mouse lymphoma cells. Mutation Res. 16:1972;77-87.
2. M.L. Applegate, J.C. Hozier, On the complexity of mutagenic events at the mouse lymphoma tk locus, in: M.M. Moore, D. DeMarini, F. de Serres, K.R. Tindall (Eds.), Banbury Report, Vol. 28, Mammalian Cell Mutagenesis, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 213-224.
3. Applegate M.L., Moore M.M., Broder C.C., Burrell A., Juhn G., Kasweck K.L., Lin P.-F., Wadhams A., Hozier J.C. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc. Natl. Acad. Sci. USA. 87:1990;51-55.
4. ± mouse lymphoma cells. Mutagenesis. 5:1990;191-197.
5. Liechty M.C., Hassanpour Z., Hozier J.C., Clive D. Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations. Mutagenesis. 9:1994;423-427.
6. Zhang L.-S., Honma M., Matsuoka A., Suzuki T., Sofuni T., Hayashi M. Chromosome painting analysis of spontaneous and methyl methanesulfonate-induced trifluorothymidine-resistant L5178Y cell colonies. Mutation Res. 370:1996;181-190.
7. ± cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutation Res. 373:1997;157-165.
8. ±3.7.2.C mouse lymphoma cell line. Mutation Res. 147:1985;243-253.
9. Hozier J., Applegate M., Moore M.M. In vitro mammalian mutagenesis as a model for genetic lesions in human cancer. Mutation Res. 270:1992;201-209.
10. Gallie B.L., Worton R.G. Somatic events unmask recessive cancer genes to initiate malignancy. J. Cell Biochem. 32:1986;215-222.
11. Harris C.C. Tumour suppressor genes, multistage cancer and molecular epidemiology. IARC Sci. Publ. 116:1992;67-85.
12. Combes R.D., Stopper H., Caspary W.J. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals. Mutagenesis. 10:1995;403-408.
13. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genotoxicity assays. Science. 236:1987;933-941.
14. Garriott M.L., Casciano D.A., Schechtman L.M., Probst G.S. International Workshop on Mouse Lymphoma Assay Testing Practices and Data Interpretations: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen. 25:1995;162-164.
15. ± mouse lymphoma forward mutation assay using 42 chemicals. Mutation Res. 125:1984;291-306.
16. Caspary W.J., Myhr B. Mutagenicity of methylisocyanate and its reaction products to cultured cells. Mutation Res. 174:1986;285-293.
17. - mouse lymphoma cell forward mutation assay to coded chemicals. I: Results for nine compounds. Environ. Mutagen. 9:1987;143-160.
18. - mouse lymphoma cell forward mutation assay. II: 8 coded chemicals Environ. Mol. Mutagen. 11:1988;91-118.
19. - mouse lymphoma cell forward mutation assay. III. 72 coded chemicals Environ. Mol. Mutagen. 12:1988;85-154.
20. McGregor D.B., Brown A.G., Cattanach P., Shepherd W., Riach C., Daston D.S., Caspary W.J. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine. Carcinogenesis. 10:1989;2003-2008.
21. Myhr B., McGregor D., Bowers L., Riach C., Brown A.G., Edwards I., McBride D., Martin R., Caspary W.J. L5178Y mouse lymphoma cell mutation assay results with 41 compounds. Environ. Mol. Mutagen. 16(Suppl. 18):1990;138-167.
22. McGregor D., Brown A.G., Cattanach P., Edwards I., McBride D., Riach C., Shepherd W., Caspary W.J. Responses of the L5178Y mouse lymphoma cell forward mutation assay: V. Gases and vapors. Environ. Mol. Mutagen. 17:1991;122-129.
23. McGregor D.B., Brown A.G., Howgate S., McBride D., Riach C., Caspary W.J. Responses of the L5178Y mouse lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ. Mol. Mutagen. 17:1991;196-219.
24. Myhr B.C., Caspary W.J. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: Results for 31 coded compounds in the National Toxicology Program. Environ. Mol. Mutagen. 18:1991;51-83.
25. Klopman G., Rosenkranz H.S. Prediction of carcinogenicity/mutagenicity using MULTICASE. Mutation Res. 305:1994;33-46.
26. Liu M., Grant S.G., Macina O.T., Klopman G., Rosenkranz H.S. Structural and mechanistic bases for the induction of mitotic chromosomal loss and duplication ('malsegregation') in the yeast Saccharomyces cerevisiae: Relevance to human carcinogenesis and developmental toxicity. Mutation Res. 374:1997;209-231.
27. Mersch-Sundermann V., Klopman G., Rosenkranz H.S. Chemical structure and genotoxicity: Studies of the SOS chromotest. Mutation Res. 340:1996;81-91.
28. Zhang Y.P., van Praagh A., Klopman G., Rosenkranz H.S. Structural basis of the induction of unscheduled DNA synthesis in rat hepatocytes. Mutagenesis. 9:1994;141-149.
29. Yang W.-L., Klopman G., Rosenkranz H.S. Structural basis of the in vivo induction of micronuclei. Mutation Res. 272:1992;111-124.
30. Rosenkranz H.S., Ennever F.K., Dimayuga M., Klopman G. Significant differences in the structural basis of the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Environ. Mol. Mutagen. 16:1990;149-177.
31. Rosenkranz H.S., Klopman G. The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: The National Toxicology Program data base. Mutation Res. 228:1990;51-80.
32. Klopman G. MULTICASE 1. A hierarchical Computer Automated Structure Evaluation program. Quant. Struct.-Act. Relat. 11:1992;176-184.
33. Klopman G., Rosenkranz H.S. Quantification of the predictivity of some short term assays for carcinogenicity in rodents. Mutation Res. 253:1991;237-240.
34. Rosenkranz H.S., Klopman G. Structural evidence for a dichotomy in rodent carcinogenesis: Involvement of genetic and cellular toxicity. Mutation Res. 303:1993;83-89.
35. Rosenkranz H.S., Zhang Y.P., Klopman G. Evidence that cell toxicity may contribute to the genotoxic response. Regul. Toxicol. Pharmacol. 19:1994;176-182.
36. Liu M., Sussman N., Klopman G., Rosenkranz H.S. Estimation of the optimal data base size for structure-activity analyses: The Salmonella mutagenicity data base. Mutation Res. 358:1996;63-72.
37. Klopman G. A semiempirical treatment of molecular structures. I. Electronegativity and atomic terms. J. Am. Chem. Soc. 86:1964;1463-1469.
38. Pearson R.G. Absolute electronegativity and hardness correlated with molecular orbital theory. Proc. Natl. Acad. Sci. USA. 83:1986;8440-8441.
39. Houser J.J., Klopman G. A new tool for the rapid estimation of charge distribution. J. Computat. Chem. 9:1988;893-904.
40. Houser J.J., Klopman G. The rapid estimation of charge distribution. II. Heteroatoms. J. Computat. Chem. 13:1992;990-996.
41. Klopman G., Wang S. A Computer Automated Structure Evaluation (CASE) approach to calculation of partition coefficient. J. Computat. Chem. 12:1991;1025-1032.
42. Klopman G., Wang S., Balthasar D.M. Estimation of aqueous solubility of organic molecules by the group contribution approach. Application to the study of biodegradation. J. Chem. Inf. Comp. Sci. 32:1992;474-482.
43. Liu M., Sussman N., Klopman G., Rosenkranz H.S. Structure-activity and mechanistic relationships: The effects of chemical overlap on structural overlap in data bases of varying size and composition. Mutation Res. 372:1996;79-85.
44. ter Haar E., Day B.W., Rosenkranz H.S. Direct tubulin polymerization perturbation contributes significantly to the induction of micronuclei in vivo. Mutation Res. 350:1996;331-337.
45. Zhang Y.P., Sussman N., Klopman G., Rosenkranz H.S. Development of methods to ascertain the predictivity and consistency of SAR models: Application to the U.S. National Toxicology Program rodent carcinogenicity bioassays. Quant. Struct.-Act. Relat. 16:1997;1-6.
46. Takihi N., Zhang Y.P., Klopman G., Rosenkranz H.S. An approach for evaluating and increasing the informational content of mutagenicity and clastogenicity data bases. Mutagenesis. 8:1993;257-264.
47. Rosenkranz H.S., Takihi N., Klopman G. Structure activity-based predictive toxicology: An efficient and economical method for generating non-congeneric data bases. Mutagenesis. 6:1991;391-394.
48. Ashby J., Paton D. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 52 different chemical carcinogen exposures. Mutation Res. 286:1993;3-74.
49. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Res. 257:1991;229-306.
50. Ashby J., Tennant R.W. Prediction of rodent carcinogenicity for 44 chemicals: Results. Mutagenesis. 9:1994;7-15.
51. Gold L.S., Manley N.B., Slone T.H., Garfinkel G.B., Rohrbach L., Ames B.N. The fifth plot of the Carcinogenic Potency Database: Results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. Environ. Health Perspect. 100:1993;65-135.
52. S.G. Grant, Mutation, segregation, and childhood cancer, in: D.M. Green, G.J. D'Angio (Eds.), Late Effects of Treatment for Childhood Cancer, Wiley-Liss, New York, 1992, Curr. Clin. Oncol. 2, pp. 121-132.
53. Johnson R.T., Rasko I., Collins A.R.S. Abnormal mutation frequencies in human repair-deficient hybrid cell lines. Mutation Res. 184:1987;113-120.
54. ±3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei. Mutation Res. 253:1991;55-62.
55. Tates A.D., Bernini L.F., Natarajan A.T., Ploem J.S., Verwoed N.P., Cole J., Green M.H., Arlett C.F., Norris P.N. Detection of somatic mutants in man: HPRT mutations in lymphocytes and hemoglobin mutations in erythrocytes. Mutation Res. 213:1989;73-82.
56. Stout J.T., Caskey C.T. HPRT: gene structure, expression, and mutation. Annu. Rev. Genet. 19:1985;127-148.
57. Cariello N.F., Skopek T.R. In vivo mutation at the human HPRT locus. Trends Genet. 9:1993;322-326.
58. Grant S.G., Bigbee W.L. In vivo somatic mutation and segregation at the human glycophorin A (GPA) locus: phenotypic variation encompassing both gene-specific and chromosomal mechanisms. Mutation Res. 288:1993;163-172.
59. Grist S.A., McCarron M., Kutlaca A., Turner D.R., Morley A.A. In vivo human somatic mutation: frequency and spectrum with age. Mutation Res. 266:1992;189-196.
60. R.G. Worton, S.G. Grant, Segregation-like events in Chinese hamster cells, in: M.M. Gottesman (Ed.), Molecular Cell Genetics, Wiley, New York, 1985, pp. 831-867.
61. ± mouse lymphoma specific gene and chromosomal mutation assay. A phase III report of the U.S. Environmental Protection Agency Gene-Tox program, Mutation Res., (1997) in press.
62. A.D. Mitchell, A.E. Auletta, D. Clive, P.E. Kirby, M.M. Moore, Check your premises: a comparison of the NTP and Gene-Tox evaluations of the utility of the L5178Y mouse lymphoma cell mutation assay for predicting rodent carcinogenicity, Mutation Res., (1997) in press.
63. Mitchell A.D. Alternate hypothesis for the bimodal size distribution of mutant colonies of L5178Y mouse lymphoma cells. Environ. Mol. Mutagen. 29:1997;431-433.